ClinicalTrials.Veeva

Menu
Layrek Clinical Research | Tulsa, OK logo

Layrek Clinical Research | Tulsa, OK

Research site

Site insights

Top conditions

Top treatments

BMS-986278
PF-07275315
Nalbuphine
Albuterol Sulfate
Lunsekimig
Fluticasone Propionate

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

6 of 7 total trials

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in participants with Idiopathic Pulmonary Fibrosis.

Active, not recruiting
Idiopathic Pulmonary Fibrosis
Drug: BMS-986278
Drug: BMS-986278 Placebo

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.

Active, not recruiting
Progressive Pulmonary Fibrosis
Drug: BMS-986278 Placebo
Drug: BMS-986278

The purpose of this clinical trial is to learn about the effects and safety of the study medicine PF-07275315 for the potential treatment of COPD. CO...

Enrolling
Moderate to Severe Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: PF-07275315-dose 2

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of...

Enrolling
Asthma
Other: Placebo
Drug: PF-07275315

This is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimi...

Enrolling
Chronic Obstructive Pulmonary Disease
Drug: Lunsekimig
Drug: Placebo

The primary purpose is to evaluate the safety and efficacy of NAL ER for the treatment of chronic cough in participants with Idiopathic Pulmonary Fib...

Enrolling
Idiopathic Pulmonary Fibrosis
Drug: NAL ER
Drug: Placebo

Trial sponsors

Bristol-Myers Squibb (BMS) logo
Pfizer logo
Sanofi logo
T
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems